Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

The BEACON Study (Breast Cancer Outcomes With NKTR-102)

ClinicalTrials.gov ID: NCT01492101

Public ClinicalTrials.gov record NCT01492101. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 9:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The BEACON Study (Breast Cancer Outcomes With NKTR-102): A Phase 3 Open-Label, Randomized, Multicenter Study of NKTR-102 Versus Treatment of Physician's Choice (TPC) in Patients With Locally Recurrent or Metastatic Breast Cancer Previously Treated With an Anthracycline, a Taxane and Capecitabine

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The study is designed as an open-label, randomized, parallel, two arm, multicenter, international Phase 3 study in patients with recurrent or metastatic breast cancer previously treated with cytotoxic chemotherapy regimens. The primary study objective is to compare overall survival of patients who receive NKTR-102 given once every 21 days to patients who receive treatment of Physician's Choice selected from a list of seven single-agent intravenous therapies.

Study identification

NCT ID
NCT01492101
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Nektar Therapeutics
Industry
Enrollment
852 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2011 (Type not available)
Primary completion
Apr 2016 (Actual)
Completion
Jun 2016 (Actual)
Last update posted
Jun 1, 2021

2011 – 2016

United States locations

U.S. sites
88
U.S. states
31
U.S. cities
77
Facility City State ZIP Site status
Arizona Oncology Associates, PC - NAHOA Flagstaff Arizona 86001 —
Providence Health System - Southern California d/b/a Roy and Patricia Disney Family Cancer Center Burbank California 91505 —
University of Southern California Los Angeles California 90033 —
PMK Medical Group, Inc., DBA Ventura County Hematology Oncology Specialists Oxnard California 93030 —
Wilshire Oncology Medical Group, Inc. Pasadena California 91105 —
Desert Hematology Oncology Medical Group Rancho Mirage California 92270 —
University of California San Francisco San Francisco California 94143 —
Stanford University School of Medicine Stanford California 94305 —
Kaiser Permanente Vallejo California 94589 —
Rocky Mountain Cancer Centers Denver Colorado 80220 —
Pre clinical Science Bldg LR3 Washington D.C. District of Columbia 20007 —
Medstar Washington D.C. District of Columbia 20010 —
Mayo Clinic in Florida Jacksonville Florida 32224 —
University of Miami School of Medicine Miami Florida 33136 —
Advanced Medical Specialties Miami Florida 33176 —
Florida Cancer Research Institute Plantation Florida 33324 —
Hematology Oncology Associates of the Treasure Coast Port Saint Lucie Florida 34592 —
Northeast Georgia Cancer Care Athens Georgia 30607 —
Peachtree Hematology Oncology Consultants Atlanta Georgia 30318 —
Emory University Atlanta Georgia 30322 —
Central Georgia Cancer Care Macon Georgia 31201 —
Northwest Georgia Oncology Centers, P.C. Marietta Georgia 30060 —
Summit Cancer Care, P.C. Savannah Georgia 31405 —
The University of Chicago Medicine Chicago Illinois 60637 —
Oncology Specialists Niles Illinois 60714 —
Illinois Cancer Care, P.C. Peoria Illinois 61547 —
IU Health Simon Cancer Center Indianapolis Indiana 46202 —
Hall-Perrine Cancer Center, 3rd Floor Cedar Rapids Iowa 52403 —
Kansas City Cancer Center Overland Park Kansas 66210 —
Louisville Oncology Clinical Research Program Louisville Kentucky 40207 —
Maryland Oncology Hematology, P.A. Columbia Maryland 21044 —
Minnesota Oncology Hematology, P.A. Minneapolis Minnesota 55404 —
University of Minnesota Minneapolis Minnesota 55455 —
Mayo Clinic Rochester Minnesota 55905 —
Coborn Cancer Center Saint Cloud Minnesota 56303 —
Missouri Cancer Associates Columbia Missouri 65201 —
Washington University in St. Louis St Louis Missouri 63110 —
Missouri Baptist Medical Center St Louis Missouri 63131 —
Frontier Cancer Center and Blood Institute Billings Montana 59102 —
Dartmouth-Hitchcock Medical Center Lebanon New Hampshire 03756 —
Hematology-Oncology Associates of Northern NJ, PA Morristown New Jersey 07962 —
The cancer Institute of New Jersey New Brunswick New Jersey 08901 —
Cooper University Hospital Voorhees Township New Jersey 08043 —
UNM Cancer Center Albuquerque New Mexico 87106 —
New York Oncology Hematology, P.C. Albany New York 12206 —
Beth Israel Medical Center New York New York 10003 —
Cornell University New York New York 10065 —
SUNY Upstate Medical University Syracuse New York 13210 —
Monte fiore The Bronx New York 10461 —
Sciode Medical Associates, PLLC, d.b.a. Eastchester Center for Cancer Care The Bronx New York 10469 —
Carolinas Hematology Oncology Associates Charlotte North Carolina 28202 —
DUMC, Duke South Durham North Carolina 27710 —
Sanford Research/USD Fargo North Dakota 58122 —
University of Cincinnati Cincinnati Ohio 45267-0502 —
Comprehensive Breast Cancer Columbus Ohio 43212 —
Signal Point Clinical Research Center Middletown Ohio 45042 —
Northwest Cancer Specialists, P.C. Portland Oregon 97225 —
Medical Oncology Associates of Wyoming Valley, PC Kingston Pennsylvania 18704 —
Cancer Centers of the Carolinas Easley South Carolina 29640 —
Sanford Research/USD Sioux Falls South Dakota 57104 —
The West Clinic Memphis Tennessee 38120 —
Sarah Cannon Research Institute (SCRI) Nashville Tennessee 37203 —
Sarah Cannon Research Institute Nashville Tennessee 37203 —
Texas Oncology-Abilene Abilene Texas 79606 —
Texas Oncology-Austin Midtown Austin Texas 78705 —
Texas Oncology-Beaumont, Mamie McFaddin Ward Cancer Center Beaumont Texas 77702 —
Texas Oncology-Bedford Bedford Texas 76022 —
Texas Oncology-Medical City Dallas Dallas Texas 75230 —
Texas Oncology-Dallas Presbyterian Hospital Dallas Texas 75231 —
Texas Oncology-Baylor Charles A. Sammons Cancer Center Dallas Texas 75246 —
Texas Oncology-Denton South Denton Texas 76210 —
Texas Oncology-Fort Worth Fort Worth Texas 76104 —
Texas Oncology-Memorial City Houston Texas 77024 —
Texas Oncology-Lewisville Lewisville Texas 75067 —
Texas Oncology-Mesquite Mesquite Texas 75150 —
Texas Oncology-Midland Allison Cancer Center Midland Texas 79701 —
Texas Oncology, P.A. - Plano Plano Texas 92270 —
Cancer Care Centers of South Texas San Antonio Texas 78217 —
Texas Oncology - Sherman Sherman Texas 75090 —
Texas Oncology-Tyler Tyler Texas 75702 —
University of Virginia Charlottesville Virginia 22908 —
Virginia Oncology Associates Norfolk Virginia 23502 —
Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care Salem Virginia 24153 —
Virginia Mason Medical Center Seattle Washington 98101 —
Seattle Cancer Care Alliance Seattle Washington 98109 —
Cancer Care Northwest Spokane Washington 99202 —
Yakima Valley Memorial Hospital/North Star Lodge Yakima Washington 98902 —
Cancer TEAM Bellin Health Green Bay Wisconsin 54313 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 65 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01492101, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 1, 2021 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01492101 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →